Register
Sign In
login
Home
Documents
Browse All »
All Docs
Docstore
Legal
Business
Personal Finance
Technology
Education
Jobs & Careers
Tax
Real Estate
Current Events
Politics & History
Guides
Science
Entertainment
Health & Fitness
Medicine
Conferences
Art & Literature
Lifestyle
Travel
Templates
Resources
Browse All »
Premium Documents
Document Packages
Courses
Videos
Licenses & DBAs
Upload
Share Documents
Sell Documents
Premium
NEW
DocStore
All Documents
DocStore
Legal
Business
Personal Finance
Technology
Education
Jobs & Careers
Tax
Real Estate
Current Events
Politics & History
Guides
Science
Entertainment
Health & Fitness
Medicine
Conferences
Art & Literature
Lifestyle
Travel
Templates
Clean Technology
Find premium clean technology research reports. Purchase and download high quality report analysis, environmental reports, technology reports, renewable research reports, reports on solar, wind, ethonal, algae, clean coal, and much more
DocStore Search:
all docs
Academia
Agreements
Books
Business Resources
Legal Forms
Periodicals
Research Reports
Templates
DocStore
»
GlobalData
»
Research Reports
»
Clean Technology
most recent
most viewed
price
alphabetically
Partners:
all partners
GlobalData
View All Categories
Research Reports
all
Alternative Energy
Clean Technology
Energy
Medical Devices
Per Page:
15
25
50
«
1
2
3
4
...
23
Next »
Fresenius Medical Care Holdings, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Fresenius Medical Care Holdings, Inc. (Fresenius Medical) d.b.a Fresenius Medical Care North America is a medical device company. It offers a broad range of dialysis products and services to individuals with chronic kidney failure. The company provides dialysis treatment at its clinics and also sells its products to other dialysis service providers. It offers services for clinical laboratory testing, therapeutic aphaeresis, inpatient dialysis, and hemoperfusion among others. Fresenius Medical carries its operations through two business divisions, namely, dialysis services and dialysis products. The company is one of the leading producer and distributor of equipment and related products for hemodialysis. It is also a leading manufacturer of peritoneal dialysis products. Fresenius Medical’s dialysis services segment provides dialysis services, laboratory services, Fresenius UltraCare program and other related services. Fresenius Medical is a subsidiary of Fresenius Medical Care AG & Co. KGaA and is headquartered in Waltham, the US.
Medy-Tox Inc. (086900) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Medy-tox Inc. (Medy-tox) is a biotechnology company. Its key products include botulinum toxin and biopharmaceuticals. The company’s products are used in cosmetic field including plastic surgery, facial wrinkle reduction, muscular relaxation. It is also used in area of muscular contractive therapy for people with blepharospasm, cerebral palsy and others. In addition, the company developed a hyaluronic acid based dermal filler injection and rapid diagnostic kit for botulinum and anthrax toxins. Medy-tox’s Microbial Toxin Research and development center facility carries out manufacturing of Botulinum toxin products with advanced technologies. The company also exports its products across 40 countries including Japan, Thailand, India, and Brazil. The company has its operations across 50 countries in Asia, Europe and America. As of 2012, the company completed product registrations across 25 countries. Medy-tox is headquartered at Chungbuk, Korea.
Symyx Technologies, Inc. (SMMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Symyx Technologies, Inc. (Symyx) is a public scientific company. The company's product portfolio comprises of software, databases, tools and workflows. It offers research and technology development services for executing and analyzing tens of thousands of highly reproducible experiments to develop optimal solutions. It enables life sciences companies’, chemicals and energy, and consumer and industrial products to transform scientific R&D for better productivity. The research experiments find application in research formulations, catalysis, life sciences, performance materials and structural materials and blends. In addition, the company provides consulting services: strategic consulting, tactical problem solving, on-site assistance and custom projects. Symyx is headquartered at Sunnyvale, in California, the US. Recently the company is mergered with Accelrys, Inc.
AbGenomics International, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
AbGenomics International, Inc. (AbGenomics) is a privately held biopharmaceutical company, engaged in the discovery and development of novel therapeutic monoclonal antibodies. The company’s products are used for the treatment of immune related inflammatory diseases such as autoimmune diseases, allergy, asthma, and transplantation rejection and cancer. AbGenomics is developing its lead therapeutic antibody under the collaborated with Boehringer Ingelheim. It is also collaborated with various corporates for the development of monoclonal antibody products. The company's research and development center located at Taipei, Taiwan focuses on the discovery and development of novel therapeutics for the unmet medical needs. AbGenomics is headquartered in California, the US.
Santen Pharmaceutical Co., Ltd. (4536) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Santen Pharmaceutical Co., Ltd. (Santen) is a Japan-based pharmaceutical company. It conducts the research, development, manufacture and commercialization of pharmaceuticals, over-the-counter (OTC) drugs and medical devices to protect and improve people's eyesight and health. The company specializes in the field of ophthalmology. Santen’s product portfolio includes ophthalmic products, anti-rheumatics, OTC pharmaceuticals, other drugs and medical devices. The company has manufacturing plants and laboratories in Japan, China and Finland. It has subsidiaries in Japan, the Netherlands, the US, Finland, France, Germany, Sweden, China, India and Korea. Santen is headquartered in Higashiyodogawa-ku, Osaka, Japan.
PharmAthene, Inc. (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
PharmAthene, Inc. (PharmAthene) is a pharmaceutical and health care service provider, based in the US. The company develops and commercializes medical counter measures to a range of biological and chemical weapons. It has built a product pipeline of new human therapeutics and prophylactics for the treatment and prevention of morbidity and mortality from exposure to chemical and biological weapons, and cultivated a strong reputation within the industry. The company’s products include sparvax a recombinant protective antigen (rPA) anthrax vaccine, valortim a fully human monoclonal antibody antitoxin for the treatment of anthrax, and recombinant BChE bioscavenger for the prevention and treatment of nerve agent poisoning. Its government and corporate partners include Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID), the Defense Advanced Research and Project Agency (DARPA), the US Army Medical Research and Material Command (USAMRMC), the US Army Medical Research Institute of Chemical Defense (USAMRICD), the U.K. Defense Science and Technology Laboratory (dstl), Bristol-Myers Squibb (formerly Medarex) and Diosynth RTP. PharmaAthene is headquartered in Annapolis, Maryland, the US.
PharmAust Limited (PAA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
PharmAust Limited (PharmAust) is a biopharmaceutical company, based in Australia. The company manufactures, sells, and markets healthcare, cosmetic and pharmaceutical products. It delivers synthetic and medicinal chemistry services. PharmAust offers research and development activities through its subsidiary Epichem Pty Ltd. The company operates with Commonwealth Biotechnologies Inc, a life sciences R&D outsourcing and offers synthetic and analytical technologies in the areas of biodefense, laboratory support and contract research. It markets and distributes its products in the domestic and international markets. The company was incorporated in the year 2003. PharmAust is headquartered in Nedlands, Australia.
Pharmanet Group Ltd (PNO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Pharmanet Group Limited (Pharmanet) is a biopharmaceutical company, based in Australia. The company manufactures and distributes pharmaceutical products. Its products include ThermaLIFE, RED and Savantac. PharmAust offers ThermaLIFE cream for use as a temporary relief from muscular and arthritic pain. Its product Savantac, a line-extension of ThermaLIFE Cream that is targeted at the acute musculoskeletal inflammatory market. The company offers RED, which is designed for the treatment of acute sun burn. Pharmanet conducts research and development activities for drug development and cosmetic industry. It markets and distributes its products in the domestic and international markets. Pharmanet is headquartered in Leederville, Western Australia, Australia.
Peregrine Pharmaceuticals, Inc. (PPHM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Peregrine Pharmaceuticals Inc. (Peregrine) is a pharmaceutical company, based in the US. The company develops and manufactures monoclonal antibodies for the treatment of cancer and serious viral infections. Its products include Bavituximab, PGN650 and Cotara. Peregrine’s Bavituximab is a monoclonal antibody that binds to a basic component of the cell structure called a phospholipid. The company offers contract manufacturing service. It utilizes technologies that include phosphatidylserine (PS)-targeting therapy for cancers and viral diseases and tumor necrosis therapy. The company has collaboration with Merck KgaA, Stason Pharmaceuticals and Affitech AS to develop its product pipeline. Peregrine is headquartered in Tustin, California, the US.
PLx Pharma Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
PLx Pharma Inc. (PLx Pharma) is a biopharmaceutical company, based in the US. The company develops non-steroidal anti-inflammatory drugs which serves for severe pain and also caters to the needs of the cardiovascular market. Its products include Oral Rx products, Oral OTC products, IV products, PL 1100 and 1200 ibuprofen, PL 3100 naproxen and PL 2200 aspirin. PLx Pharma focuses on the development its products in the areas of osteoarthritis, pain, fever and cardio prevention. The company entered into a development and commercialization agreement for a proprietary mesalamine-based (5-ASA) technology in the treatment of Inflammatory Bowel Disease. PLx Pharma is headquartered in Houston, Texas, the US.
Five Prime Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Five Prime Therapeutics, Inc. (FivePrime) is a pharmaceutical and health care service provider, based in the US. The company discovers and develops protein and antibody therapeutics. It offers drugs for oncology, immunology, and diabetes and regenerative medicine. The company has strategic collaborations with Pfizer, Inc. in the fields of oncology and diabetes, GlaxoSmithKline for skeletal muscle disorders, Human Genome Sciences, Inc. for development and commercialization in the US, Canada, and EU FP1039 for solid, Centocor in the field of pulmonary fibrosis and osteoarthritis, Boehringer Ingelheim in the field of rheumatoid arthritis and also with Biosite and Dnaform. FivePrime is headquartered in San Francisco, California, the US.
Boston Biomedical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Boston Biomedical, Inc. (BBI) is a biotechnology company, based in the US. The company conducts research and develops novel therapeutics to treat cancer. It focuses on the study of biomarkers for ArQule's lead cancer therapeutics. BBI provides ARQ 501, ARQ 197, ARQ 171 and ARQ 450RP programs. Its ARQ 501 is an activated checkpoint therapy-based small molecule that selectively kills cancer cells through E2F1-mediated DNA damage checkpoint pathway. ARQ 197 is a non-ATP selective c-met inhibitor. The company’s ARQ 171 is a pathway activator. Its ARQ 450RP is a clinical candidate selection stage program on mitotic checkpoint activators. The company operates as a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. BBI is headquartered in Norwood, Massachusetts, the US.
Kolltan Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Kolltan Pharmaceuticals, Inc. (Kolltan) is a pharmaceutical company, based in the US. The company develops monoclonal antibody related oncology therapeutics. Its products are based on receptor tyrosine kinases. Kolltan has licensing agreement with Dr. Schlessinger's Laboratory, for the development of therapeutic molecules for the treatment of oncology diseases. The company supports receptor tyrosine kinase research in the Schlessinger Laboratory under the agreement with Yale University. It aims to develop therapeutic human mAbs. The company was founded in the year 2007. The company operates through its laboratories. Kolltan is headquartered in New Haven, Connecticut, the US.
Asahi Kasei Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Asahi Kasei Pharma Corporation (Asahi Kasei Pharma) is a pharmaceutical company, based in Japan. It provides pharmaceutical and diagnostic reagent. The company offers enzyme products such as Human Enzymes, Dehydrogenase, Hydrolase, Isomerase, Ligase, Lyase, Oxidase and Transferase. Asahi Kasei Pharma provides feed additives, diagnostic reagents, nutritional products, and animal health products. It also offers contact lenses. The company provides products under different brand names that include Elcitonin, Bredinin, Flivas, Toledomin and Lucica. It operates as a subsidiary of Asahi Kasei Group. The company offers its products in domestic and international markets. Asahi Kasei Pharma is headquartered in Chiyoda-ku, Tokyo, Japan.
Cell Medica Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
$250.00
$250.00
From:
GlobalData
Document Overview:
Cell Medica Limited (Cell Medica) is a healthcare company, based in the UK. It is in the development of cell therapies for the treatment of various diseases. The company is a partnership of scientists, clinicians, investors and universities to develop immunotherapy to the patients. The research partners of the company include University College London, Royal Free Hospital, University of Wurzburg and Imperial College London. It is focused on various clinical applications like cell therapy, infection from cytomegalovirus (CMV) after allogeneic haematopoietic stem cell (bone marrow) transplant and cancer. Recently, the company has inked a research and development agreement with The Center for Cell and Gene Therapy (CAGT), to commercialize clinically proven cell therapies which have been pioneered by the CAGT, which has the potential to treat certain hematological malignancies associated with oncogenic viruses. Cell Medica is headquartered in London, the UK.
Per Page:
15
25
50
«
1
2
3
4
...
23
Next »